Bisoprolol Fumarate tablets, 5 mg, 30-count bottles, Rx only, Manufactured by: UNICHEM LABORATO...

FDA Drug Recall #D-0010-2018 — Class II — October 2, 2017

Recall Summary

Recall Number D-0010-2018
Classification Class II — Moderate risk
Date Initiated October 2, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Unichem Pharmaceuticals Usa Inc
Location Hasbrouck Heights, NJ
Product Type Drugs
Quantity 96,876 bottles

Product Description

Bisoprolol Fumarate tablets, 5 mg, 30-count bottles, Rx only, Manufactured by: UNICHEM LABORATORIES, LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa, 403 511, India, Marketed by: UNICHEM PHARMACEUTICALS, (USA), INC. Hasbrouck Heights, NJ 07604, NDC 29300-126-13.

Reason for Recall

Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.

Distribution Pattern

Product was distributed nationwide

Lot / Code Information

Lot #: GBOL16001, GBOL16002, Exp 12/31/2017; GBOL16015, Exp 03/31/2018.

Other Recalls from Unichem Pharmaceuticals Usa Inc

Recall # Classification Product Date
D-1541-2022 Class III Clonidine Hydrochloride Tablets, USP, 0.3 mg, 1... Sep 19, 2022
D-0255-2022 Class III Topiramate Tablets, USP 50 mg, 500-count bottle... Oct 25, 2021
D-1291-2020 Class III Clonidine Hydrochloride Tablets, USP 0.1 mg 100... May 26, 2020
D-0829-2020 Class III Clonidine Hydrochloride Tablets, USP 0.1mg, Rx ... Jan 29, 2020
D-0228-2018 Class II Divalproex Sodium Delayed Release Tablets USP, ... Dec 19, 2017

Frequently Asked Questions

Nitrosamines are probable human carcinogens — they can increase cancer risk with long-term exposure above certain thresholds, but they do not cause immediate harm from taking a single dose. The FDA calculates an acceptable daily intake (ADI) for each nitrosamine compound, and recalls are triggered when levels exceed this threshold. If you have been taking a recalled product, the FDA generally advises against abruptly stopping your medication (especially for critical conditions like blood pressure or diabetes) until you consult your doctor. The incremental cancer risk from short-term exposure is very small.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.